Nextgen Biotech

Call us:

Cresp 200mcg - Darbepoetin Alfa Injection

Cresp 200mcg is a long-acting erythropoiesis-stimulating agent (ESA) used for treating anemia associated with chronic kidney disease (CKD) and chemotherapy. It stimulates the production of red blood cells by mimicking the effects of natural erythropoietin, reducing the need for blood transfusions.

Choose Quantity:

-
+
Share
General Information:
Generic Name: Darbepoetin Alfa
Brand Name: Cresp
Packing: Pre-filled syringe or vial
Strength: 200mcg per injection
Manufacturer: Dr. Reddy’s Laboratories
Form: Injectable Solution
Category: Erythropoiesis-Stimulating Agent (ESA)
Product Introduction:
Cresp 200mcg is a synthetic erythropoiesis-stimulating agent (ESA) designed to treat anemia in patients with chronic kidney disease (CKD) or those undergoing chemotherapy. By increasing red blood cell production, it helps improve oxygen transport in the body, reducing symptoms like fatigue, weakness, and dizziness.

Uses of Cresp 200mcg
Cresp 200mcg is used to treat anemia caused by the following conditions:
  1. Chronic Kidney Disease (CKD): Helps maintain hemoglobin levels and reduces the need for blood transfusions.
  2. Chemotherapy-Induced Anemia: Used in cancer patients undergoing chemotherapy to manage anemia.
  3. HIV-Associated Anemia: Helps boost red blood cell production in HIV-positive patients suffering from anemia.
  4. Pre-Surgical Use: Reduces the need for blood transfusions before major surgeries.
  5. Bone Marrow Disorders: Used in certain bone marrow conditions leading to low red blood cell production.

How Cresp 200mcg Works (Mechanism of Action)
Darbepoetin Alfa is a synthetic form of erythropoietin that stimulates the bone marrow to produce red blood cells. It binds to erythropoietin receptors on red blood cell precursors in the bone marrow, leading to increased red blood cell production.
  1. It has a longer half-life than natural erythropoietin, allowing less frequent dosing.
  2. By increasing hemoglobin levels, it helps reduce the need for blood transfusions and improves oxygen supply to the body.

Dosage of Cresp 200mcg
Typical Recommended Dose:
  1. Chronic Kidney Disease (CKD):
    1. Initial Dose: 0.45 mcg/kg once weekly or 0.75 mcg/kg once every two weeks.
    2. Maintenance Dose: Adjust based on hemoglobin levels; may be administered every two weeks or monthly.
  2. Chemotherapy-Induced Anemia:
    1. Initial Dose: 2.25 mcg/kg once weekly or 500 mcg every three weeks.
    2. Maintenance Dose: Adjust based on response and hemoglobin levels.
  3. Surgical Anemia:
    1. Administered before major surgeries to reduce the need for blood transfusions.
💡 Dosing is customized based on hemoglobin levels and patient response.

Method of Administration (How to Take It)
  1. Injection Route:
    1. Subcutaneous (under the skin): Preferred for long-term treatment.
    2. Intravenous (IV): Commonly used in dialysis patients or hospital settings.
  2. Self-Administration:
    1. Patients can be trained to inject themselves at home.
    2. Injection Sites: Usually given in the abdomen, thigh, or upper arm.
⚠️ Follow proper injection technique and consult your doctor for guidance.

Side Effects of Cresp 200mcg
Common Side Effects:
  1. Fatigue
  2. Headache
  3. Nausea and vomiting
  4. Muscle or joint pain
  5. Mild injection site reactions (redness, swelling, pain)
Serious Side Effects (Seek Immediate Medical Help):
  1. High Blood Pressure (Hypertension): Can lead to severe headaches or blurred vision.
  2. Blood Clots (Thrombosis): May cause deep vein thrombosis (DVT) or pulmonary embolism.
  3. Heart Attack or Stroke: Increased risk in patients with a history of cardiovascular diseases.
  4. Severe Allergic Reactions: Rash, swelling, or difficulty breathing.
  5. Seizures: Rare but possible in some patients.
🚨 Regular monitoring is essential to avoid serious complications.

Precautions Before Taking Cresp 200mcg
  1. Hypertension: Monitor blood pressure regularly as the drug can cause high blood pressure.
  2. Heart Disease: Patients with cardiovascular conditions should use with caution.
  3. Iron Levels: Ensure sufficient iron levels for the medication to work effectively.
  4. Pregnancy & Breastfeeding: Consult a doctor before use.
  5. Allergy Warning: Do not use if allergic to Darbepoetin or its ingredients.
  6. Kidney Failure Patients: Require careful dose adjustments.

Drug Interactions (Medications That May Interact)
  1. Antihypertensive Drugs: Can affect blood pressure control.
  2. Iron Supplements: Often required to enhance effectiveness.
  3. Blood Thinners (Anticoagulants): May increase the risk of blood clots.
  4. Other ESAs (Erythropoiesis-Stimulating Agents): Should not be combined without doctor’s approval.
  5. Chemotherapy Drugs: Requires careful monitoring when used together.

Allergy Warnings
  1. Do not take if allergic to Darbepoetin or any ingredients in the injection.
  2. Symptoms of severe allergy: Rash, swelling, or difficulty breathing.
  3. Seek immediate medical help if an allergic reaction occurs.

Storage Instructions
  1. Store in a refrigerator between 2°C to 8°C (36°F to 46°F).
  2. Do not freeze.
  3. Keep in original packaging to protect from light.
  4. Keep out of reach of children.

Overdose Information
Symptoms of Overdose:
  1. High blood pressure
  2. Severe headaches or dizziness
  3. Shortness of breath or chest pain
What to Do in Case of Overdose?
  1. Seek emergency medical attention immediately.
  2. Monitor blood pressure and cardiovascular function.
  3. Doctor may reduce dosage or temporarily discontinue the medication.

Missed Dose Instructions
  1. If you miss a dose: Take it as soon as possible unless it’s near the next dose.
  2. Do not double the dose to make up for the missed one.
  3. Consult your doctor for further guidance.

In The Same Category

Cart